Although estrogen receptor (ESR1 or ERα protein) involvement in NSCLC progression is still controversial, ESR1 modulates NSCLC development and progression, triggering EGFR as well as the Wnt/β-catenin pathways. This evidence concerns the gene ESR1 and non-small cell lung carcinoma.